Skip to main content
SpringerLink
Log in

Contaminated heparin: the CDC investigation

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Blossom DB, Kallen AJ, Patel PR, Elward A, Robinson L, Gao G, Langer R, Perkins KM, Jaeger JL, Kurkjian KM, Jones M, Schillie SF, Shehab N, Ketterer D, Venkataraman G, Kishimoto TK, Shriver Z, McMahon AW, Austen KF, Kozlowski S, Srinivasan A, Turabelidze G, Gould CV, Arduino MJ, Sasisekharan R.Outbreak of adverse reactions associated with contaminated heparin. New England Journal of Medicine 359: 2674-2684, No. 25, 18 Dec 2008

  2. Alban S, Lühn S.Prothrombin time for detection of contaminated heparins. New England Journal of Medicine 359: 2732-2734, No. 25, 18 Dec 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Contaminated heparin: the CDC investigation. React. Wkly. 1232, 3 (2008). https://doi.org/10.2165/00128415-200812320-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812320-00006

Keywords

Search

Navigation